|
시장보고서
상품코드
2064810
인슐린 패치 펌프 시장 규모, 점유율 및 성장 분석 : 유형별, 인슐린 유형별, 기술별, 용도별, 최종사용자별, 유통경로별, 지역별 - 업계 예측(2026-2033년)Insulin Patch Pumps Market Size, Share, and Growth Analysis, By Type (Tethered Patch Pumps, Tubeless Patch Pumps), By Insulin Type, By Technology, By Application, By End-User, By Distribution, By Region - Industry Forecast 2026-2033 |
||||||
세계의 인슐린 패치 펌프 시장 규모는 2024년에 15억 2,000만 달러로 평가되었고, 2025년 17억 1,000만 달러에서 2033년까지 45억 2,000만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 12.82%를 기록할 것으로 예측됩니다.
인슐린 패치 펌프 시장은 인슐린 의존성 당뇨병 유병률 증가와, 복약 순응도 및 전반적인 삶의 질을 향상시키는 눈에 띄지 않고 사용하기 편리한 치료법에 대한 환자들 수요에 힘입어 크게 성장하고 있습니다. 이러한 혁신적인 튜브리스 장치는 투여 과정을 간소화하면서도 지속적인 인슐린 투여를 가능하게 합니다. 마이크로플루이딕스공학의 기술 발전과 규제 당국의 승인을 배경으로, 시장은 부피가 큰 외부 펌프에서 정교한 접착 패치 시스템으로 전환되고 있으며, 이로 인해 채택이 확대되고 투자 기회가 창출되고 있습니다. 시장 성장에 영향을 미치는 중요한 요인 중 하나는 연속 혈당 모니터링(CGM) 및 헬스케어 플랫폼과의 상호운용성입니다. 이를 통해 원활한 데이터 교환이 가능해지며, 인슐린 투여량의 자동 조절 및 임상 모니터링이 지원됩니다. 패치 펌프와 CGM, 그리고 알고리즘 제어 장치의 결합은 환자의 예후 개선으로 이어지고 있으며, 이는 보험사 측의 수용을 더욱 촉진하고 환자의 접근성을 확대되고 있습니다.
세계 인슐린 패치 펌프 시장의 성장 요인
인슐린 패치 펌프 세계 시장은 인슐린 치료가 필요한 환자 수 증가에 힘입어 눈부신 성장을 이루고 있습니다. 환자와 의료진이 치료 순응도와 관리 수준을 높이기 위해 침습성이 낮고 편의성이 뛰어난 투여 방법을 찾는 가운데, 인슐린 패치 펌프의 인기가 높아지고 있습니다. 이 콤팩트하고 튜브가 없는 설계는 일상적인 투여 과정을 간소화할 뿐만 아니라, 눈에 잘 띄는 인슐린 투여 기기로 인해 발생하는 사회적 편견을 완화함으로써, 결과적으로 다양한 환자층에서의 보급을 촉진하고 있습니다. 이에 대응하여 각 제조업체는 사용자 친화적인 제품 개발과 이러한 혁신 기술을 촉진하기 위한 인식 제고 캠페인 전개에 주력하고 있으며, 그 결과 임상 현장에서의 수용도가 높아져 환자의 삶의 질(QOL) 향상으로 이어지고 있습니다.
세계 인슐린 패치 펌프 시장의 제약 요인
인슐린 패치 펌프와 관련된 고액의 비용(초기 구입 비용과 지속적인 소모품 비용을 모두 포함)은 많은 환자와 의료 시스템에 있어 큰 경제적 장벽이 되고 있으며, 이로 인해 신속한 보급이 저해되고 있습니다. 게다가, 미흡한 보상 제도와 보험 적용 범위의 불일치가 이러한 경제적 문제를 더욱 심화시키고 있어, 잠재적 이용자들은 기존 방식 중 비용 대비 효과가 더 높은 대안을 선택할 수밖에 없는 실정입니다. 이러한 경제적 제약으로 인해 의료 제공업체의 조달 결정이 지연될 가능성이 있으며, 시장의 성장은 주로 부유층이나 자원이 풍부한 의료 환경으로 한정될 우려가 있습니다. 그 결과, 제조업체가 판매망을 확대하고 인슐린 패치 펌프 기술을 보다 광범위하게 활용할 수 있는 능력이 제한될 수밖에 없습니다.
세계 인슐린 패치 펌프 시장 동향
세계 인슐린 패치 펌프 시장에서는 이러한 기기가 소비자용 및 임상용 디지털 생태계와 통합되는 것을 배경으로, 연결형 당뇨병 관리를 향한 뚜렷한 추세가 나타나고 있습니다. 패치 펌프가 모바일 애플리케이션, 클라우드 컴퓨팅, 원격 의료 서비스와의 상호 운용성을 높여감에 따라, 데이터의 원활한 흐름이 가능해지며, 원격 투여량 조절, 개인 맞춤형 알림, 연계된 치료 경로가 촉진됩니다. 이러한 발전은 환자의 참여도를 높일 뿐만 아니라, 임상의의 업무 흐름을 효율화하고 있습니다. 의료기기 제조업체, 소프트웨어 개발사, 의료 네트워크 간의 전략적 제휴를 통해 서비스 제공 내용이 충실해진 한편, 안전한 데이터 교환과 사용자 친화적인 인터페이스에 대한 강한 중시가 시장에서의 수용성을 높이고, 환자의 장기적인 충성도를 키워가고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 인슐린 패치 펌프 시장 규모 : 유형별
세계의 인슐린 패치 펌프 시장 규모 : 인슐린 유형별
세계의 인슐린 패치 펌프 시장 규모 : 기술별
세계의 인슐린 패치 펌프 시장 규모 : 용도별
세계의 인슐린 패치 펌프 시장 규모 : 최종사용자별
세계의 인슐린 패치 펌프 시장 규모 : 유통별
세계의 인슐린 패치 펌프 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.06.29Global Insulin Patch Pumps Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.71 Billion in 2025 to USD 4.52 Billion by 2033, growing at a CAGR of 12.82% during the forecast period (2026-2033).
The insulin patch pumps market is significantly driven by the increasing incidence of insulin-dependent diabetes and patient preferences for discreet, user-friendly treatment options that enhance adherence and overall quality of life. These innovative, tubeless devices facilitate continuous insulin delivery while simplifying dosing. The market has transitioned from bulky external pumps to sleek adhesive patch systems, fueled by technological advancements in microfluidics and regulatory approvals, leading to greater adoption and investment opportunities. A vital factor influencing market growth is the interoperability with continuous glucose monitors and health platforms, which allows for seamless data exchange that supports automated insulin adjustments and clinical supervision. The combination of patch pumps with CGMs and algorithmic controllers has been linked to improved patient outcomes, further driving payer acceptance and broadening patient access.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Patch Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Insulin Patch Pumps Market Segments Analysis
Global insulin patch pumps market is segmented by type, insulin type, technology, application, end-user, distribution and region. Based on type, the market is segmented into Tethered Patch Pumps and Tubeless Patch Pumps. Based on insulin type, the market is segmented into Rapid-Acting Insulin and Long-Acting Insulin. Based on technology, the market is segmented into Closed-Loop (Artificial Pancreas) and Open-Loop. Based on application, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on end-user, the market is segmented into Hospitals, Home Care and Ambulatory Diabetes Centers. Based on distribution, the market is segmented into Direct, Pharmacies and Online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Insulin Patch Pumps Market
The global market for insulin patch pumps is experiencing significant growth driven by the rising prevalence of individuals requiring insulin therapy. As patients and healthcare providers look for less invasive and more convenient delivery methods to enhance treatment adherence and management, insulin patch pumps are becoming increasingly popular. Their compact and tubeless design not only simplifies daily routines but also alleviates any stigma linked to more visible insulin delivery devices, thereby encouraging wider adoption among various patient populations. In response, manufacturers are focusing on developing user-friendly products and launching awareness campaigns to promote these innovations, which leads to greater acceptance in clinical environments and improved patient quality of life.
Restraints in the Global Insulin Patch Pumps Market
The high expenses linked to insulin patch pumps, encompassing both the initial purchase and ongoing consumable costs, present a significant financial hurdle for numerous patients and healthcare systems, hindering swift adoption. Additionally, insufficient reimbursement frameworks and inconsistencies in insurance coverage amplify these affordability issues, compelling potential users to opt for conventional, more cost-effective alternatives. These economic limitations may delay procurement choices made by healthcare providers and confine market growth primarily to affluent demographics or well-resourced healthcare environments. Consequently, this restricts manufacturers' ability to expand distribution and attain broader utilization of insulin patch pump technology.
Market Trends of the Global Insulin Patch Pumps Market
The Global Insulin Patch Pumps market is witnessing a notable trend towards connected diabetes management, driven by the integration of these devices with consumer and clinical digital ecosystems. As patch pumps enhance their interoperability with mobile applications, cloud computing, and telehealth services, they enable a seamless flow of data that facilitates remote titration, personalized reminders, and coordinated care pathways. This advancement is not only improving patient engagement but also streamlining clinician workflows. Strategic partnerships among device manufacturers, software developers, and healthcare networks are enriching service offerings, while a strong emphasis on secure data exchange and user-friendly interfaces enhances market acceptance and fosters long-term patient loyalty.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Insulin Patch Pumps Market Size by Type & CAGR (2026-2033)
- Market Overview
- Tethered Patch Pumps
- Tubeless Patch Pumps
Global Insulin Patch Pumps Market Size by Insulin Type & CAGR (2026-2033)
- Market Overview
- Rapid-Acting Insulin
- Long-Acting Insulin
Global Insulin Patch Pumps Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Closed-Loop (Artificial Pancreas)
- Open-Loop
Global Insulin Patch Pumps Market Size by Application & CAGR (2026-2033)
- Market Overview
- Type 1 Diabetes
- Type 2 Diabetes
Global Insulin Patch Pumps Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Home Care
- Ambulatory Diabetes Centers
Global Insulin Patch Pumps Market Size by Distribution & CAGR (2026-2033)
- Market Overview
- Direct
- Pharmacies
- Online
Global Insulin Patch Pumps Market Size & CAGR (2026-2033)
- North America (Type, Insulin Type, Technology, Application, End-User, Distribution)
- US
- Canada
- Europe (Type, Insulin Type, Technology, Application, End-User, Distribution)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Insulin Type, Technology, Application, End-User, Distribution)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Insulin Type, Technology, Application, End-User, Distribution)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Insulin Type, Technology, Application, End-User, Distribution)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Insulet Corporation (Omnipod)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (MiniMed)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tandem Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton Dickinson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CeQur Corporation (PaQ)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche (Accu-Chek Solo)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ypsomed AG (mylife YpsoPump)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enable Injections
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sensile Medical (Gerresheimer)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PHC Holdings (Phchd)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sooil Development (Dana)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Debiotech SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microport Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kaleido Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diabeloop SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beta Bionics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bigfoot Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dexcom (CGM integration)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
